医学
经颈静脉肝内门体分流术
肝性脑病
肝移植
倾向得分匹配
门脉高压
内科学
混淆
回顾性队列研究
终末期肝病模型
生存分析
队列
肝硬化
外科
移植
作者
Yi Xiang,Jun Tie,Guangchuan Wang,Yuzheng Zhuge,Hao Wu,Xiaoli Zhu,Hui Xue,Shanghao Liu,Ling Yang,Jiao Xu,Feng Zhang,Mingyan Zhang,Bo Wei,Peijie Li,Ze Wang,Wei Wu,Chao Chen,Shifeng Yang,Yicheng Han,Chengwei Tang
摘要
Transjugular intrahepatic portosystemic shunt (TIPS) is an established procedure for managing portal hypertension in cirrhotic patients, but the impact of post-TIPS overt hepatic encephalopathy (OHE) on survival remains controversial. While its effect on short-term survival is well-documented, its long-term implications remain unclear. This study aims to investigate the long-term impact of post-TIPS OHE on mortality in cirrhotic patients for variceal bleeding, focusing on the timing and predictive value of OHE beyond the first year post-TIPS. A multicenter, retrospective cohort study was conducted involving 3262 cirrhotic patients who underwent TIPS for variceal bleeding at seven Chinese tertiary centers between January 2010 and June 2020. Clinical data, including demographics, procedure details, post-TIPS complications and survival outcomes, were collected. The primary endpoints were all-cause mortality and OHE, with follow-up until death, liver transplantation or 60 months. Propensity score matching minimised confounding effects, and multivariate Fine-Grey competing risk models identified independent mortality predictors. During a median follow-up of 1077 days, 33.2% developed post-TIPS OHE, associated with higher MELD and Child-Pugh scores. Among these, 19.3% died, with a median time from OHE onset to death of 947 days. Post-TIPS OHE was not linked to early survival (within 12 months) but emerged as an independent predictor of long-term mortality beyond 24 months, consistent across various clinical scenarios. Post-TIPS OHE does not affect short-term survival but significantly increases long-term mortality risk. These findings highlight the need for continuous monitoring and tailored interventions to improve long-term outcomes in post-TIPS patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI